Abstract
The hemostimulating effect of erythropoietin immobilized by the nanotechnology method of electron-beam synthesis was studied on the model of carboplatin-induced myelosuppression. Subcutaneous injection or oral administration of immobilized erythropoietin was followed by stimulation of erythropoiesis. The effect was most pronounced after parenteral treatment with this agent. The increase in proliferative activity and maturation of erythroid precursor cells serve as a factor determining acceleration of reparative processes in the hemopoietic tissue.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anemia / blood
-
Anemia / chemically induced
-
Anemia / drug therapy
-
Animals
-
Bone Marrow / drug effects
-
Bone Marrow / pathology
-
Carboplatin
-
Cell Count
-
Cells, Cultured
-
Drug Carriers / chemistry*
-
Erythropoietin / chemistry
-
Erythropoietin / pharmacokinetics
-
Erythropoietin / pharmacology*
-
Erythropoietin / therapeutic use
-
Hematopoiesis / drug effects
-
Immobilized Proteins / chemistry
-
Immobilized Proteins / pharmacology*
-
Immobilized Proteins / therapeutic use
-
Mice
-
Mice, Inbred CBA
-
Nanotechnology
-
Polyethylene Glycols / chemistry*
-
Reticulocytes / drug effects
-
Reticulocytes / pathology
Substances
-
Drug Carriers
-
Immobilized Proteins
-
Erythropoietin
-
Polyethylene Glycols
-
Carboplatin